Home
Squadron Capital Management reported a 6.9% stake in C4 Therapeutics CCCC · 7,600,000 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 6.9%
- Last report
- 5% · filed 26/05/19
- Shares held
- 7,600,000 sh
- Class
- Common Stock, $0.0001 par value per share
- Stock
- C4 Therapeutics CCCC
- Event date
- 26/06/30
- Filed
- 26/08/14
6.9% stake · +1.9pp from the last report
- Stake
- 6.9%
- Last report
- 5%
- Since last report
- +1.9pp
C4 Therapeutics trades, last 26 weeks
What else happened in C4 Therapeutics around then
Filed or reported within 30 days of the trade day · 05/31~07/30Squadron Capital Management's other 5% stake reports
- Squadron Capital Management
5% stakeTraws Pharma
5% stakeTraws Pharma
TRAW
0% stake
0 sh
0% stake
Filed 08/14
- Squadron Capital Management
5% stakeRelmada Therapeutics
5% stakeRelmada Therapeutics
RLMD
7% stake
7,350,000 sh
7% stake
Filed 08/14
- Squadron Capital Management
5% stakeNextCure
5% stakeNextCure
NXTC
1.6% stake
64,464 sh
1.6% stake
Filed 08/14
- Squadron Capital Management
5% stakeLipocine
5% stakeLipocine
LPCN
9.8% stake
810,000 sh
9.8% stake
Filed 08/14
- Squadron Capital Management
5% stakeQuince Therapeutics
5% stakeQuince Therapeutics
QNCX
5.6% stake
55,173 sh
5.6% stake
Filed 08/04
